Stay updated with breaking news from Preclinical Programs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dr. Moore will lead Zymeworks’ Early Research & Development Group responsible for advancing the Company’s next-generation of multispecific antibody programs and antibody drug... | June 27, 2022
MONT-SAINT-GUIBERT, Belgium, May 05, 2022 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Celyad Oncology SA (Euronext...
- Accepted abstracts include preclinical data on JAG101, an investigational gene therapy designed to address the root cause of Type 1 galactosemiaLAKE FOREST, Ill.--(BUSINESS WIRE)--Jaguar Gene Therapy, a biotechnology company accelerating breakthroughs in gene therapy for patients suffering from severe genetic dise...